Guardian Pharmacy Services (GRDN) reported preliminary Q4 income Monday of $10.1 million to $11.1 million, down by $3.5 million to $4.5 million from a year earlier.
Three analysts polled by FactSet expect $10.5 million.
Revenue for the quarter ended Dec. 31 is expected to be $338.6 million, up 20.5% from a year earlier.
Three analysts surveyed by FactSet expect $320.5 million.
For 2025, the company expects revenue of $1.33 billion to $1.35 billion. Three analysts polled by FactSet expect $1.33 billion.
Shares of the company were down nearly 10% in recent premarket activity.
Price: 18.01, Change: -1.99, Percent Change: -9.95
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。